Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Net Change in Cash

Rigel Pharmaceuticals Net Change in Cash Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Net Change in Cash from 2010 to 2020.
  • Rigel Pharmaceuticals Net Change in Cash for the quarter ending June 06, 2020 was $-9m a 41.34% decrease of -4m year over year
  • Rigel Pharmaceuticals Net Change in Cash for the last 12 months ending June 06, 2020 was $-8m a -188.57% increase of 15m year over year
  • Rigel Pharmaceuticals Annual Net Change in Cash for 2019 was $-54m a 170.69% decrease of -92m from 2018
  • Rigel Pharmaceuticals Annual Net Change in Cash for 2018 was $38m a 45.68% increase of 17m from 2017
  • Rigel Pharmaceuticals Annual Net Change in Cash for 2017 was $21m a 225.01% increase of 46m from 2016
Other Cash Flow Metrics:
  • Rigel Pharmaceuticals Cash Flow from Operations for the quarter ending December 12, 2018 was $12m a 300.91% increase of 35m year over year
  • Rigel Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $1m a 1,495.75% increase of 15m year over year
  • Rigel Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $5m a 26.33% increase of 1m year over year
View Chart On Koyfin

Quarterly RIGL Net Change in Cash Data

06/2020$-9m
03/2020$23m
12/2019$-17m
09/2019$-5m
06/2019$-30m
03/2019$-2m
12/2018$15m
09/2018$-4m
06/2018$25m
03/2018$2m

Annual RIGL Net Change in Cash Data

2019$-54m
2018$38m
2017$21m
2016$-26m
2015$28m
2014$-6m
2013$-13m
2012$15m
2011$10m
2010$-6m